IP Library Granted Patent US 9,593,309
Granted Patent B2
US 9,593,309 · App. 14/707,564 · Granted Mar 14, 2017

Media for culturing, preserving, and administering regenerative cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,593,309
App. No.
14/707,564
Granted
Mar 14, 2017
Kind
B2
Abstract

A culture media, media supplement, or soluble matrix for cryopreservation or enhanced regenerative cell growth in culture and maintenance of multi-lineage differentiation potentiation. The inventive culture media, media supplement, or soluble matrix comprises a GAG composition comprising a sulfated GAG, such as chondroitin sulfate. A soluble matrix, a cell administration package or kit comprising the soluble matrix and a device for cell administration, and a method of use thereof, for administration of regenerative cells for treating a joint disease or other weakened or damaged tissue comprising the specified GAG compositions are further provided.

Claims (10)

1. A method of culturing cells having multi-lineage differentiation potential, comprising culturing the cells for at least 24 hours in a cell culture media comprising a glycosaminoglycan (GAG) composition, wherein said GAG composition comprises hyaluronic acid, chondroitin sulfate and N-acetyl D-glucosamine in a relative weight ratio of 1:20:20, wherein said GAG composition is at a concentration of 5-10% (v/v), and wherein the cultured cells have an enhanced in vitro expansion rate and maintain multi-lineage differentiation potential compared to cells having a multi-lineage differentiation potential not cultured in the media.

2. The method of claim 1 , wherein said composition is at a concentration of 5-7% (v/v).

3. The method of claim 2 , wherein said composition is at a concentration of 5% (v/v).

4. The method of claim 1 , wherein said GAG composition comprises hyaluronic acid, CS4 and CS6 chondroitin sulfate and N-acetyl D-glucosamine at a concentration 5-10% (v/v).

5. The method of claim 1 , wherein said cells are treated with a media supplement comprising the GAG composition and then culturing the cells.

6. The method of claim 1 , wherein said cells are grown on a surface coated with a soluble matrix comprising the GAG composition.

7. The method of claim 1 , wherein said cell is an adipose-derived mesenchymal stem cell (Ad-MSC).

8. The method of claim 1 , wherein the cells are cultured for at least 3 days.

9. The method of claim 1 , wherein the cells are cultured for at least 6 days.

10. The method of claim 1 , wherein the GAG composition comprises about 5 mg/ml hyaluronic acid sodium salt, about 100 mg/ml sodium chondroitin sulfate, and about 100 mg/ml N-acetyl D-glucosamine.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2017
From: ARTHRODYNAMIC TECHNOLOGIES, ANIMAL HEALTH DIVISION, INC.
To: ARTHRODYNAMIC HOLDINGS, LLC
Reel/Frame 040854/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2015
From: MARCUM, FRANK D.; SHEALY, PAUL
To: ARTHRODYNAMIC TECHNOLOGIES, ANIMAL HEALTH DIVISION, INC.
Reel/Frame 035604/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2015
From: ALT, ECKHARD U.; COLEMAN, MICHAEL E.; MARTINEZ, RUDY F.; BRUNO, IVONE G.; SANCHEZ, AMIR
To: INGENERON INCORPORATED
Reel/Frame 035604/0988 →